![Michel Morre](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michel Morre is the founder of Cytheris SA, which was founded in 1999.
He held the titles of President & Chief Executive Officer from 2011 to 2013.
Dr. Morre also worked as a Principal at Sanofi.
He received an undergraduate degree from Université Fédérale Toulouse Midi-Pyrénées.
| Companies | Position | End |
|---|---|---|
Cytheris SA
 Cytheris SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for immune modulation | Founder | - |
| SANOFI | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 3 |
|---|---|
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Cytheris SA
Cytheris SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for immune modulation | Health Technology |
Université Fédérale Toulouse Midi-Pyrénées
 Université Fédérale Toulouse Midi-Pyrénées Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions
